[Breast pathology 2014].
Institut für Pathologie, Medizinische Hochschule Hannover, Carl-Neuberg-Str.1, 30625, Hannover, Deutschland, Kreipe.Hans@mh-hannover.de.
H H
HH
Kreipe
D001940:Breast / Q000473:pathology; D001943:Breast Neoplasms / Q000145:classification / Q000235:genetics / Q000473:pathology* / Q000628:therapy; D003131:Combined Modality Therapy; D005260:Female; D020869:Gene Expression Profiling; D005819:Genetic Markers / Q000235:genetics; D006801:Humans; D009376:Neoplasms, Hormone-Dependent / Q000145:classification / Q000235:genetics / Q000473:pathology; D057285:Precision Medicine; D011379:Prognosis; D018719:Erb-b2 Receptor Tyrosine Kinases / Q000235:genetics; D064726:Triple Negative Breast Neoplasms / Q000145:classification / Q000235:genetics / Q000473:pathology / Q000628:therapy
D005819:Genetic Markers; D018719:Erb-b2 Receptor Tyrosine Kinases; C508053:ERBB2 protein, human